BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Breast cancer AND DNAJB1, HSPF1, 3337, ENSG00000132002, P25685, Hdj1, Hsp40 AND Treatment
9 results:

  • 1. Rural-urban differences in secular trends of locoregional treatment for ductal carcinoma in situ: A patterns of care analysis.
    Riley D; Chrischilles EA; Lizarraga IM; Charlton M; Smith BJ; Lynch CF
    Cancer Med; 2022 Jun; 11(11):2284-2295. PubMed ID: 35146946
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. miR-1205/dnajb1 reverses docetaxel chemoresistance in human triple negative breast carcinoma cells via regulation of mutp53/TAp63 signaling.
    Yin Y; Zhang J; Ma T; Chen D; Lu D
    Acta Biochim Biophys Sin (Shanghai); 2022 Jan; 54(1):37-46. PubMed ID: 35130632
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. MicroRNAs and Heat Shock Proteins in breast cancer Biology.
    Yildiz MT; Tutar L; Giritlioğlu NI; Bayram B; Tutar Y
    Methods Mol Biol; 2022; 2257():293-310. PubMed ID: 34432285
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Evaluation of the Role of Human DNAJAs in the Response to Cytotoxic Chemotherapeutic Agents in a Yeast Model System.
    Whitmore A; Freeny D; Sojourner SJ; Miles JS; Graham WM; Flores-Rozas H
    Biomed Res Int; 2020; 2020():9097638. PubMed ID: 32149145
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Knockdown of microRNA-29a Changes the Expression of Heat Shock Proteins in breast Carcinoma MCF-7 Cells.
    Choghaei E; Khamisipour G; Falahati M; Naeimi B; Mossahebi-Mohammadi M; Tahmasebi R; Hasanpour M; Shamsian S; Hashemi ZS
    Oncol Res; 2016 Jan; 23(1-2):69-78. PubMed ID: 26802653
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Design of novel Geldanamycin analogue hsp90 alpha-inhibitor in silico for breast cancer therapy.
    Mahanta S; Pilla S; Paul S
    Med Hypotheses; 2013 Sep; 81(3):463-9. PubMed ID: 23860250
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. The usefulness of Tc-99m-tetrofosmin SPECT/CT in the detection of residual tumors and axillary lymph node metastases in breast cancer patients following neoadjuvant therapy.
    Spanu A; Sanna D; Chessa F; Farris A; Nuvoli S; Madeddu G
    Clin Nucl Med; 2011 Nov; 36(11):997-1002. PubMed ID: 21975387
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Dose-dense chemotherapy in nonmetastatic breast cancer: a systematic review and meta-analysis of randomized controlled trials.
    Bonilla L; Ben-Aharon I; Vidal L; Gafter-Gvili A; Leibovici L; Stemmer SM
    J Natl Cancer Inst; 2010 Dec; 102(24):1845-54. PubMed ID: 21098761
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. JDP1 (DNAJC12/hsp40) expression in breast cancer and its association with estrogen receptor status.
    De Bessa SA; Salaorni S; Patrão DF; Neto MM; Brentani MM; Nagai MA
    Int J Mol Med; 2006 Feb; 17(2):363-7. PubMed ID: 16391838
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.